Marshall Wace, LLP Amgen Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Amgen Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 705,111 shares of AMGN stock, worth $203 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

705,111

Previous 656,498 7.4%

Holding current value

$203 Million

Previous $205 Million 10.76%

% of portfolio

0.29%

Previous 0.28%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $15 Million - $16.4 Million	48,613 Added 7.4%	705,111 $227 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $45.5 Million - $55.3 Million	173,058 Added 35.8%	656,498 $205 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $93.1 Million - $112 Million	346,399 Added 252.77%	483,440 $137 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $361 Million - $407 Million	-1,411,187 Reduced 91.15%	137,041 $39.5 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $291 Million - $362 Million	1,332,231 Added 616.78%	1,548,228 $416 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $15.5 Million - $18.3 Million	72,266 Added 50.28%	215,997 $48 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $19.1 Million - $23.2 Million	84,380 Added 142.17%	143,731 $34.7 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $4.63 Million - $5.88 Million	-20,213 Reduced 25.4%	59,351 $15.6 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $40.1 Million - $45.2 Million	-178,664 Reduced 69.19%	79,564 $17.9 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $14.2 Million - $15.8 Million	-61,702 Reduced 19.29%	258,228 $62.8 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $47.1 Million - $52.2 Million	215,015 Added 204.94%	319,930 $77.4 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $20.3 Million - $23.2 Million	102,066 Added 3582.52%	104,915 $23.6 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $8.5 Million - $9.95 Million	-40,020 Reduced 93.35%	2,849 $606,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $4.57 Million - $5.07 Million	-19,556 Reduced 31.33%	42,869 $10.4 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $11.3 Million - $13.2 Million	51,049 Added 448.74%	62,425 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $1.23 Million - $1.47 Million	5,686 Added 99.93%	11,376 $2.62 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $15.5 Million - $17.2 Million	-65,905 Reduced 92.05%	5,690 $1.45 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $13.2 Million - $16.2 Million	66,642 Added 1345.49%	71,595 $16.9 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $902,634 - $1.2 Million	4,953 New	4,953 $1 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $136,798 - $175,833	-723 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $4.39 Million - $5.26 Million	-25,201 Reduced 97.21%	723 $140,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $4.32 Million - $5.07 Million	25,924 New	25,924 $4.78 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Amgen Inc Transaction History